GPCR — Structure Therapeutics Share News
0.000.00%
Last trade - 00:00Factbox: The race to launch first weight-loss pill
Structure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Factbox: Drugmakers racing to launch the first weight-loss pill
Structure Therapeutics Q2 net loss widens
Structure Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Structure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Structure Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Eli Lilly soars as pill leads to 7.9% weight loss in late-stage trial
Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trial
Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trial
OPKO and Entera partner to develop obesity pill
U.S. STOCKS ON THE MOVE-HubSpot, Casey's General Stores, ANI Pharma
U.S. STOCKS ON THE MOVE-Corvus, Dogwood Therapeutics, Uranium Energy
Some obesity drug developers rise after Zealand Pharma-Roche deal
U.S. STOCKS ON THE MOVE-Intel, Groupon, Stitch Fix
U.S. STOCKS ON THE MOVE-Intel, Groupon, Stitch Fix
Lilly falls, while some obesity drug developers rise after Zealand Pharma-Roche deal
U.S. STOCKS ON THE MOVE-Moderna, Hims & Hers Health, Carrier